1. Home
  2. BRR vs DRTS Comparison

BRR vs DRTS Comparison

Compare BRR & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRR
  • DRTS
  • Stock Information
  • Founded
  • BRR 2024
  • DRTS 2015
  • Country
  • BRR United States
  • DRTS Israel
  • Employees
  • BRR N/A
  • DRTS N/A
  • Industry
  • BRR Blank Checks
  • DRTS Medical/Dental Instruments
  • Sector
  • BRR Finance
  • DRTS Health Care
  • Exchange
  • BRR Nasdaq
  • DRTS Nasdaq
  • Market Cap
  • BRR 344.8M
  • DRTS 300.2M
  • IPO Year
  • BRR N/A
  • DRTS N/A
  • Fundamental
  • Price
  • BRR $10.22
  • DRTS $4.20
  • Analyst Decision
  • BRR
  • DRTS Strong Buy
  • Analyst Count
  • BRR 0
  • DRTS 1
  • Target Price
  • BRR N/A
  • DRTS $9.00
  • AVG Volume (30 Days)
  • BRR 412.5K
  • DRTS 60.0K
  • Earning Date
  • BRR 01-01-0001
  • DRTS 11-18-2025
  • Dividend Yield
  • BRR N/A
  • DRTS N/A
  • EPS Growth
  • BRR N/A
  • DRTS N/A
  • EPS
  • BRR N/A
  • DRTS N/A
  • Revenue
  • BRR N/A
  • DRTS N/A
  • Revenue This Year
  • BRR N/A
  • DRTS N/A
  • Revenue Next Year
  • BRR N/A
  • DRTS N/A
  • P/E Ratio
  • BRR N/A
  • DRTS N/A
  • Revenue Growth
  • BRR N/A
  • DRTS N/A
  • 52 Week Low
  • BRR $10.05
  • DRTS $2.14
  • 52 Week High
  • BRR $10.57
  • DRTS $4.69
  • Technical
  • Relative Strength Index (RSI)
  • BRR N/A
  • DRTS 56.64
  • Support Level
  • BRR N/A
  • DRTS $3.97
  • Resistance Level
  • BRR N/A
  • DRTS $4.34
  • Average True Range (ATR)
  • BRR 0.00
  • DRTS 0.28
  • MACD
  • BRR 0.00
  • DRTS -0.01
  • Stochastic Oscillator
  • BRR 0.00
  • DRTS 64.29

About BRR Columbus Circle Capital Corp I Class A Ordinary Shares

Columbus Circle Capital Corp I is a blank check company.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

Share on Social Networks: